155 related articles for article (PubMed ID: 11334653)
1. CAPRICORN: a story of alpha allocation and beta-blockers in left ventricular dysfunction post-MI.
Coats AJ
Int J Cardiol; 2001 Apr; 78(2):109-13. PubMed ID: 11334653
[TBL] [Abstract][Full Text] [Related]
2. The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials?
Otterstad JE; Ford I
Eur J Heart Fail; 2002 Aug; 4(4):501-6. PubMed ID: 12167391
[TBL] [Abstract][Full Text] [Related]
3. Landmark study: the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction Study (CAPRICORN).
Colucci WS
Am J Cardiol; 2004 May; 93(9A):13B-6B. PubMed ID: 15144931
[TBL] [Abstract][Full Text] [Related]
4. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial.
Dargie HJ
Lancet; 2001 May; 357(9266):1385-90. PubMed ID: 11356434
[TBL] [Abstract][Full Text] [Related]
5. Carvedilol: a review of its use in chronic heart failure.
Keating GM; Jarvis B
Drugs; 2003; 63(16):1697-741. PubMed ID: 12904089
[TBL] [Abstract][Full Text] [Related]
6. [Beta blockers in post-infarction state].
Schultheiss HP; Tschöpe C
Herz; 2002 Aug; 27 Suppl 1():26-9. PubMed ID: 12229255
[TBL] [Abstract][Full Text] [Related]
7. New evidence from the CAPRICORN Trial: the role of carvedilol in high-risk, post-myocardial infarction patients.
Sackner-Bernstein JD
Rev Cardiovasc Med; 2003; 4 Suppl 3():S25-9. PubMed ID: 14564231
[TBL] [Abstract][Full Text] [Related]
8. Design and methodology of the CAPRICORN trial - a randomised double blind placebo controlled study of the impact of carvedilol on morbidity and mortality in patients with left ventricular dysfunction after myocardial infarction.
Dargie HJ
Eur J Heart Fail; 2000 Sep; 2(3):325-32. PubMed ID: 10938495
[No Abstract] [Full Text] [Related]
9. Effects of carvedilol early after myocardial infarction: analysis of the first 30 days in Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN).
Fonarow GC; Lukas MA; Robertson M; Colucci WS; Dargie HJ
Am Heart J; 2007 Oct; 154(4):637-44. PubMed ID: 17892984
[TBL] [Abstract][Full Text] [Related]
10. Randomized active-controlled study comparing effects of treatment with carvedilol versus metoprolol in patients with left ventricular dysfunction after acute myocardial infarction.
Mrdovic IB; Savic LZ; Perunicic JP; Asanin MR; Lasica RM; Jelena MM; Matic MD; Vasiljevic ZM; Ostojic MC
Am Heart J; 2007 Jul; 154(1):116-22. PubMed ID: 17584563
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group.
Di Lenarda A; Sabbadini G; Salvatore L; Sinagra G; Mestroni L; Pinamonti B; Gregori D; Ciani F; Muzzi A; Klugmann S; Camerini F
J Am Coll Cardiol; 1999 Jun; 33(7):1926-34. PubMed ID: 10362195
[TBL] [Abstract][Full Text] [Related]
12. Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy.
Doughty RN; Whalley GA; Walsh HA; Gamble GD; López-Sendón J; Sharpe N;
Circulation; 2004 Jan; 109(2):201-6. PubMed ID: 14707020
[TBL] [Abstract][Full Text] [Related]
13. The carvedilol hibernation reversible ischaemia trial, marker of success (CHRISTMAS) study. Methodology of a randomised, placebo controlled, multicentre study of carvedilol in hibernation and heart failure.
Pennell DJ; Ray SG; Davies G; Burgess M; Webster J; Slomka P; Atkinson P; Cleland JG
Int J Cardiol; 2000 Feb; 72(3):265-74. PubMed ID: 10716137
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic profile of controlled-release carvedilol in patients with left ventricular dysfunction associated with chronic heart failure or after myocardial infarction.
Packer M; Lukas MA; Tenero DM; Baidoo CA; Greenberg BH;
Am J Cardiol; 2006 Oct; 98(7A):39L-45L. PubMed ID: 17023231
[TBL] [Abstract][Full Text] [Related]
15. [Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomized trial].
Costalunga A; Gavazzi A
Ital Heart J Suppl; 2001 Nov; 2(11):1246-7. PubMed ID: 11775420
[No Abstract] [Full Text] [Related]
16. Beta-blockers in heart failure. The 'new wave' of clinical trials.
Krum H
Drugs; 1999 Aug; 58(2):203-10. PubMed ID: 10473016
[TBL] [Abstract][Full Text] [Related]
17. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
Torp-Pedersen C; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Lutiger B; Metra M; Remme WJ; Scherhag A; Skene A;
Am Heart J; 2005 Feb; 149(2):370-6. PubMed ID: 15846279
[TBL] [Abstract][Full Text] [Related]
18. Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction.
Wei S; Chow LT; Sanderson JE
J Am Coll Cardiol; 2000 Jul; 36(1):276-81. PubMed ID: 10898446
[TBL] [Abstract][Full Text] [Related]
19. Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial.
McMurray J; Køber L; Robertson M; Dargie H; Colucci W; Lopez-Sendon J; Remme W; Sharpe DN; Ford I
J Am Coll Cardiol; 2005 Feb; 45(4):525-30. PubMed ID: 15708698
[TBL] [Abstract][Full Text] [Related]
20. Carvedilol: use in chronic heart failure.
Doughty RN; White HD
Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
